Maplight Therapeutics Inc (MPLT)

R&D Expense Growth

-0.46%

Quarterly · Period ending:

MPLT logo

MPLT R&D Expense Growth

Latest reported-0.46%
MPLT Quarterly R&D Growth (QoQ) (0.00% → -0.46%)
High-resolution chart · PNG

MPLT r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Maplight Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-0.4638%
-16.747%
137.9973%
1.4339%
36.1417%
-5.2769%
23.189%
8.6948%
1.7697%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.